日韩午夜精品视频,欧美私密网站,国产一区二区三区四区,国产主播一区二区三区四区

Home / Business / Healthcare & Pharmaceutical Tools: Save | Print | E-mail | Most Read | Comment
Wyeth Q2 profit up 13% to beat views
Adjust font size:

Drug maker Wyeth yesterday posted a 13 percent jump in second-quarter profit, trouncing Wall Street forecasts, as cost cuts overcame lower sales due to generic competition and the strong dollar.

The maker of children's vaccine Prevnar and antidepressant Effexor also hiked its 2009 profit forecast.

Madison, New Jersey-based Wyeth, the world's No. 12 pharmaceutical company by sales, is being bought by No. 1 drug maker Pfizer Inc later this year.

Wyeth said its net income amounted to US$1.27 billion, or 94 cents per share. That's up from US$1.12 billion, or 83 cents a share, a year earlier.

Wyeth said without US$44.9 million in restructuring costs and US$21.2 million in costs for the acquisition by Pfizer, net income would have been 98 cents per share. That was 13 cents more than Wall Street expected.

Revenue declines

Revenue dropped 4 percent, to US$5.7 billion from US$5.95 billion, as the strong dollar reduced worldwide income about 6 percentage points.

Analysts polled by Thomson Reuters were expecting earnings per share of 85 cents and revenue of US$5.58 billion.

Meanwhile, Wyeth raised its 2009 profit forecast to a range of US$3.48 to US$3.58 per share, from a range of US$3.33 to US$3.53.

On Monday, Wyeth shareholders voted overwhelmingly to approve the Pfizer deal, which still requires approval by antitrust regulators in the United States and a few other countries.

The two companies are working on selling parts of their animal health businesses to gain approval.

"We remain focused on delivering strong performance as we work with Pfizer toward the successful integration of our two companies," Wyeth Chief Executive Bernard Poussot said in a statement.

"Wyeth's results reflect the ongoing strength of our biotechnology and vaccine franchises," as well as infant formula and other nutrition items sold in many foreign countries, he said.

Excluding currency effects, sales rose 24 percent to US$783 million for Prevnar, the world's top-selling vaccine, which protects against pneumonia, meningitis and other diseases.

(Shanghai Daily July 24, 2009)

Tools: Save | Print | E-mail | Most Read Bookmark and Share
Comment
Pet Name
Anonymous
China Archives
Related >>
June 7 Tokyo 2nd China-Japan High-Level Economic Dialogu

June 30 Shanghai 2009 Automotive Engine Technology Seminar

September 8-12 Xiamen China Int'l Fair for Investment and Trade
- Output of Major Industrial Products
- Investment by Various Sectors
- Foreign Direct Investment by Country or Region
- National Price Index
- Value of Major Commodity Import
- Money Supply
- Exchange Rate and Foreign Exchange Reserve
- What does the China-Pakistan Free Trade Agreement cover?
- How to Set up a Foreign Capital Enterprise in China?
- How Does the VAT Works in China?
- How Much RMB or Foreign Currency Can Be Physically Carried Out of or Into China?
- What Is the Electrical Fitting in China?
主站蜘蛛池模板: 巨鹿县| 榆中县| 威海市| 揭西县| 阳曲县| 怀宁县| 于田县| 柘城县| 临城县| 盐池县| 砚山县| 大洼县| 武胜县| 株洲县| 巴楚县| 临猗县| 邹城市| 榆林市| 大竹县| 施秉县| 鄢陵县| 磐安县| 延庆县| 弥勒县| 依安县| 揭东县| 崇明县| 军事| 无为县| 乌海市| 麻江县| 钟祥市| 陇川县| 页游| 五常市| 鄯善县| 深泽县| 湛江市| 淅川县| 五原县| 佛教|